Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Homeobox protein Hox-C13, encoded by the HOXC13 gene, is a member of the homeobox family of transcription factors that bind DNA in a sequence-specific manner to regulate gene expression. It plays a key role in morphogenesis, specifically in hair follicle and nail development, and controls the expression of hair-specific genes such as FOXQ1. HOXC13 is implicated in the pathogenesis of certain cancers and genetic disorders like ectodermal dysplasia. Mammals possess four homeobox clusters (HOXA, HOXB, HOXC, HOXD), and HOXC13 is located in the HOXC cluster on chromosome 12.
Not applicable for approved drugs; theoretical mechanisms would include modulation of gene expression pathways (e.g., inhibition of transcriptional activity by small molecules or peptides if a drug existed)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Homeobox protein Hox-C13 (HOXC13).